FY2024 EPS Estimates for HURN Lifted by Barrington Research

Huron Consulting Group Inc. (NASDAQ:HURN) – Barrington Research raised their FY2024 earnings estimates for Huron Consulting Group in a research note issued on Monday, November 4th. Barrington Research analyst K. Steinke now anticipates that the business services provider will post earnings per share of $6.10 for the year, up from their prior forecast of $5.87. Barrington Research has a “Outperform” rating and a $142.00 price target on the stock. The consensus estimate for Huron Consulting Group’s current full-year earnings is $6.11 per share. Barrington Research also issued estimates for Huron Consulting Group’s FY2025 earnings at $6.91 EPS.

A number of other research analysts have also recently issued reports on HURN. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Benchmark reissued a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, October 30th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $133.00.

Huron Consulting Group Trading Down 0.4 %

Shares of Huron Consulting Group stock opened at $127.66 on Wednesday. Huron Consulting Group has a 12-month low of $84.26 and a 12-month high of $131.06. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock has a market cap of $2.26 billion, a PE ratio of 27.75 and a beta of 0.60. The company has a 50-day moving average of $108.91 and a two-hundred day moving average of $101.74.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.11. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company had revenue of $370.00 million during the quarter, compared to analysts’ expectations of $377.63 million. During the same period last year, the company posted $1.39 earnings per share. The firm’s quarterly revenue was up 3.3% compared to the same quarter last year.

Insider Transactions at Huron Consulting Group

In other news, CEO C. Mark Hussey sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $103.13, for a total transaction of $412,520.00. Following the completion of the transaction, the chief executive officer now directly owns 81,081 shares of the company’s stock, valued at $8,361,883.53. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Huron Consulting Group news, CEO C. Mark Hussey sold 4,000 shares of Huron Consulting Group stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $103.13, for a total value of $412,520.00. Following the completion of the sale, the chief executive officer now directly owns 81,081 shares of the company’s stock, valued at approximately $8,361,883.53. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $108.27, for a total transaction of $112,817.34. Following the completion of the sale, the director now directly owns 28,840 shares of the company’s stock, valued at $3,122,506.80. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,348 shares of company stock valued at $783,392 in the last ninety days. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Huron Consulting Group

Several hedge funds and other institutional investors have recently bought and sold shares of HURN. Quest Partners LLC boosted its holdings in shares of Huron Consulting Group by 131.9% in the 3rd quarter. Quest Partners LLC now owns 13,814 shares of the business services provider’s stock valued at $1,502,000 after purchasing an additional 7,858 shares during the last quarter. Natixis Advisors LLC boosted its holdings in shares of Huron Consulting Group by 32.7% in the 3rd quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider’s stock valued at $2,019,000 after purchasing an additional 4,576 shares during the last quarter. Chartwell Investment Partners LLC boosted its holdings in shares of Huron Consulting Group by 43.3% in the 3rd quarter. Chartwell Investment Partners LLC now owns 8,196 shares of the business services provider’s stock valued at $891,000 after purchasing an additional 2,477 shares during the last quarter. Assetmark Inc. boosted its holdings in shares of Huron Consulting Group by 7.0% in the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after purchasing an additional 90 shares during the last quarter. Finally, Olympiad Research LP acquired a new position in shares of Huron Consulting Group in the 3rd quarter valued at $299,000. 93.90% of the stock is owned by hedge funds and other institutional investors.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.